For Information Only
Res Med
have long been interested in a Australian product called Sleep Check by Resapphealth.
It has taken over 30 years of research and development by a Professor Abeyratne of Queensland University.
Today Sleep Check gained FDA approval.
For the information of ResMed holders. It may interesr some holders.
Ann: RMD to Report Third Quarter Fiscal 2022 Results, page-25
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$35.59 |
Change
-0.330(0.92%) |
Mkt cap ! $21.82B | |||
| Open | High | Low | Value | Volume |
| $35.74 | $35.87 | $35.59 | $21.77M | 610.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 621 | $35.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $35.70 | 35 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| RMD (ASX) Chart |